Global Contraceptives Market Research Report 2026(Status and Outlook)
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Contraceptives competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.In medical and regulatory contexts, the term "contraceptives" refers to pharmaceutical and device systems that prevent pregnancy by inhibiting ovulation, altering the cervical mucus and endometrial environment, or blocking fertilization/implantation. The core paradigms include oral hormonal formulations, injectable progestins, intrauterine systems (copper or levonorgestrel-releasing devices), and emergency contraceptives. Their suitability for different populations, contraindications, and adherence management are continuously updated through evidence-based guidelines and labeling, such as the U.S. CDC’s 2024 "Medical Eligibility Criteria for Contraceptive Use" and the EU/UK’s risk-benefit assessments and reclassification practices for combined hormonal and progestin-only products. These serve as the policy basis and technical foundation for prescription-to-nonprescription switches, pharmacy accessibility, and self-administration.Market Opportunities and Driving ForcesDemand-side dynamics are shaped by demographics, women's fertility intentions, and awareness of reproductive health rights. Policy-side drivers primarily include national family planning initiatives and international organizational support for accessibility. Technologically, innovation is propelled by drug molecule optimization, delivery systems, and digital health solutions (e-prescriptions, follow-ups, education), enabling new adoption scenarios. Companies recognize opportunities not only in replacing or upgrading conventional oral and barrier products but also in penetrating primary healthcare markets and youth demographics through integrated services (e.g., online consultation + offline pickup). Challenges arise from regulatory disparities, long-term safety monitoring requirements, and supply chain disruptions due to cultural or policy restrictions in certain regions. To maintain trust, enterprises must integrate rigorous clinical evidence, traceable supply chains, and collaboration with public institutions to transform opportunities into sustainable growth.Key Industry Chain: Who Captures Value?The upstream segment involves APIs, pharmaceutical excipients, CDMOs, and prescription R&D. The midstream covers formulation, medical device manufacturing, and quality control. The downstream sector is dominated by pharmacies, hospitals, family planning programs, international philanthropic procurement, and e-commerce channels. Representative multinational R&D and channel players operate across both upstream and downstream: pharmaceutical companies lead molecular innovation and registration pathways, local drugmakers and CDMOs handle scaled production, while consumer brands (e.g., condom operators) dominate end-user education and retail systems. Downstream touchpoints are diverse and sticky, making channel integration a decisive competitive advantage. Key partners include government health programs, international organizations, and local distribution networks.Growth Drivers in Sub-SectorsBy application and end-user, short-acting oral and barrier methods maintain steady demand among general prevention and first-time users. Long-acting reversible contraceptives (LARCs) and implant/intrauterine delivery systems are rising fastest among populations seeking long-term, intervention-free solutions. Digital prescription platforms and visual education services targeting adolescents and mobile populations are emerging as new growth frontiers. Meanwhile, premium differentiated products based on formulation innovations (e.g., novel estrogen molecules or milder hormonal combinations) and branded products emphasizing emotional/sexual wellness (e.g., functionalized condoms) are gaining rapid traction in consumption-upgrading markets. To succeed in sub-sectors, companies must simultaneously invest in clinical acceptability, user experience, and channel storytelling.Regional Landscape: Buyers, Producers, and TrendsettersNorth America is characterized by mature regulation, R&D-driven innovation, and insurance/prescription systems, where novel drugs and new indications are prioritized. China and Asia-Pacific exhibit a dual-track market: rapid expansion driven by massive grassroots demand and e-commerce penetration, alongside the need for localized channel innovations within specific cultural and regulatory contexts. Europe emphasizes public health procurement and high regulatory standards, prioritizing long-term safety monitoring and insurance coverage. Other regions are heavily influenced by international aid and NGO procurement, where policy or funding volatility directly impacts accessibility and supply stability. Collaboration between multinational corporations and international organizations, coupled with deep localization in distribution ecosystems, determines the implementation speed and resilience of regional markets.Latest DevelopmentsNovember 15, 2023: Bayer announced a two-year partnership with the UN Population Fund in India to expand reproductive health services for youth and couples through integrated digital and grassroots health systems?February 29, 2024: Reuters reported that Reckitt (owner of Durex) is exploring live-streaming e-commerce in China to expand condom market share. Facing regulatory constraints on sexual content, the company adopted incremental livestreaming strategies to boost online sales?August 6, 2025: Multiple media outlets cited NGO data highlighting the U.S. government's decision to handle donated contraceptive supplies, leading to the destruction of several batches. This raised concerns about aid supply chain risks and accessibility in recipient countries.
The global Contraceptives market size was estimated at USD 2008.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 2.50% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Contraceptives market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Contraceptives market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Contraceptives market.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Contraceptives Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Contraceptives, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
The global Contraceptives market size was estimated at USD 2008.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 2.50% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Contraceptives market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Contraceptives market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Contraceptives market.
Global Contraceptives Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
- Bayer
- Pfizer
- Teva
- Actavis
- Gedeon Richter
- ZiZhu
- Baijingyu
- Sine
- Reckitt
- AbbVie
- Church & Dwight
- Cooper Companies
- TherapeuticsMD
- Afaxys
- Mithra Pharmaceuticals
Market Segmentation (by Type)
- Pills
- Injectable
- Condoms
- Vaginal Rings
- IUDs
- Subdermal Implants
- Others
Market Segmentation (by Application)
- 15–24 years
- 25–34 years
- 35–44 years
- Above 44 years
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Contraceptives Market
Overview of the regional outlook of the Contraceptives Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Contraceptives Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Contraceptives, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Contraceptives
1.2 Key Market Segments
1.2.1 Contraceptives Segment by Type
1.2.2 Contraceptives Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 CONTRACEPTIVES MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Contraceptives Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Contraceptives Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 CONTRACEPTIVES MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Contraceptives Product Life Cycle
3.3 Global Contraceptives Sales by Manufacturers (2020-2025)
3.4 Global Contraceptives Revenue Market Share by Manufacturers (2020-2025)
3.5 Contraceptives Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Contraceptives Average Price by Manufacturers (2020-2025)
3.7 Manufacturers’ Manufacturing Sites, Areas Served, and Product Types
3.8 Contraceptives Market Competitive Situation and Trends
3.8.1 Contraceptives Market Concentration Rate
3.8.2 Global 5 and 10 Largest Contraceptives Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 CONTRACEPTIVES INDUSTRY CHAIN ANALYSIS
4.1 Contraceptives Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF CONTRACEPTIVES MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Contraceptives Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy – April 2025
5.6.3 Global Trade Frictions and Their Impacts to Contraceptives Market
5.7 ESG Ratings of Leading Companies
6 CONTRACEPTIVES MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Contraceptives Sales Market Share by Type (2020-2025)
6.3 Global Contraceptives Market Size by Type (2020-2025)
6.4 Global Contraceptives Price by Type (2020-2025)
7 CONTRACEPTIVES MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Contraceptives Market Sales by Application (2020-2025)
7.3 Global Contraceptives Market Size (M USD) by Application (2020-2025)
7.4 Global Contraceptives Sales Growth Rate by Application (2020-2025)
8 CONTRACEPTIVES MARKET SALES BY REGION
8.1 Global Contraceptives Sales by Region
8.1.1 Global Contraceptives Sales by Region
8.1.2 Global Contraceptives Sales Market Share by Region
8.2 Global Contraceptives Market Size by Region
8.2.1 Global Contraceptives Market Size by Region
8.2.2 Global Contraceptives Market Size by Region
8.3 North America
8.3.1 North America Contraceptives Sales by Country
8.3.2 North America Contraceptives Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Contraceptives Sales by Country
8.4.2 Europe Contraceptives Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Contraceptives Sales by Region
8.5.2 Asia Pacific Contraceptives Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Contraceptives Sales by Country
8.6.2 South America Contraceptives Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Contraceptives Sales by Region
8.7.2 Middle East and Africa Contraceptives Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 CONTRACEPTIVES MARKET PRODUCTION BY REGION
9.1 Global Production of Contraceptives by Region(2020-2025)
9.2 Global Contraceptives Revenue Market Share by Region (2020-2025)
9.3 Global Contraceptives Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Contraceptives Production
9.4.1 North America Contraceptives Production Growth Rate (2020-2025)
9.4.2 North America Contraceptives Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Contraceptives Production
9.5.1 Europe Contraceptives Production Growth Rate (2020-2025)
9.5.2 Europe Contraceptives Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Contraceptives Production (2020-2025)
9.6.1 Japan Contraceptives Production Growth Rate (2020-2025)
9.6.2 Japan Contraceptives Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Contraceptives Production (2020-2025)
9.7.1 China Contraceptives Production Growth Rate (2020-2025)
9.7.2 China Contraceptives Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Bayer
10.1.1 Bayer Basic Information
10.1.2 Bayer Contraceptives Product Overview
10.1.3 Bayer Contraceptives Product Market Performance
10.1.4 Bayer Business Overview
10.1.5 Bayer SWOT Analysis
10.1.6 Bayer Recent Developments
10.2 Pfizer
10.2.1 Pfizer Basic Information
10.2.2 Pfizer Contraceptives Product Overview
10.2.3 Pfizer Contraceptives Product Market Performance
10.2.4 Pfizer Business Overview
10.2.5 Pfizer SWOT Analysis
10.2.6 Pfizer Recent Developments
10.3 Teva
10.3.1 Teva Basic Information
10.3.2 Teva Contraceptives Product Overview
10.3.3 Teva Contraceptives Product Market Performance
10.3.4 Teva Business Overview
10.3.5 Teva SWOT Analysis
10.3.6 Teva Recent Developments
10.4 Actavis
10.4.1 Actavis Basic Information
10.4.2 Actavis Contraceptives Product Overview
10.4.3 Actavis Contraceptives Product Market Performance
10.4.4 Actavis Business Overview
10.4.5 Actavis Recent Developments
10.5 Gedeon Richter
10.5.1 Gedeon Richter Basic Information
10.5.2 Gedeon Richter Contraceptives Product Overview
10.5.3 Gedeon Richter Contraceptives Product Market Performance
10.5.4 Gedeon Richter Business Overview
10.5.5 Gedeon Richter Recent Developments
10.6 ZiZhu
10.6.1 ZiZhu Basic Information
10.6.2 ZiZhu Contraceptives Product Overview
10.6.3 ZiZhu Contraceptives Product Market Performance
10.6.4 ZiZhu Business Overview
10.6.5 ZiZhu Recent Developments
10.7 Baijingyu
10.7.1 Baijingyu Basic Information
10.7.2 Baijingyu Contraceptives Product Overview
10.7.3 Baijingyu Contraceptives Product Market Performance
10.7.4 Baijingyu Business Overview
10.7.5 Baijingyu Recent Developments
10.8 Sine
10.8.1 Sine Basic Information
10.8.2 Sine Contraceptives Product Overview
10.8.3 Sine Contraceptives Product Market Performance
10.8.4 Sine Business Overview
10.8.5 Sine Recent Developments
10.9 Reckitt
10.9.1 Reckitt Basic Information
10.9.2 Reckitt Contraceptives Product Overview
10.9.3 Reckitt Contraceptives Product Market Performance
10.9.4 Reckitt Business Overview
10.9.5 Reckitt Recent Developments
10.10 AbbVie
10.10.1 AbbVie Basic Information
10.10.2 AbbVie Contraceptives Product Overview
10.10.3 AbbVie Contraceptives Product Market Performance
10.10.4 AbbVie Business Overview
10.10.5 AbbVie Recent Developments
10.11 Church and Dwight
10.11.1 Church and Dwight Basic Information
10.11.2 Church and Dwight Contraceptives Product Overview
10.11.3 Church and Dwight Contraceptives Product Market Performance
10.11.4 Church and Dwight Business Overview
10.11.5 Church and Dwight Recent Developments
10.12 Cooper Companies
10.12.1 Cooper Companies Basic Information
10.12.2 Cooper Companies Contraceptives Product Overview
10.12.3 Cooper Companies Contraceptives Product Market Performance
10.12.4 Cooper Companies Business Overview
10.12.5 Cooper Companies Recent Developments
10.13 TherapeuticsMD
10.13.1 TherapeuticsMD Basic Information
10.13.2 TherapeuticsMD Contraceptives Product Overview
10.13.3 TherapeuticsMD Contraceptives Product Market Performance
10.13.4 TherapeuticsMD Business Overview
10.13.5 TherapeuticsMD Recent Developments
10.14 Afaxys
10.14.1 Afaxys Basic Information
10.14.2 Afaxys Contraceptives Product Overview
10.14.3 Afaxys Contraceptives Product Market Performance
10.14.4 Afaxys Business Overview
10.14.5 Afaxys Recent Developments
10.15 Mithra Pharmaceuticals
10.15.1 Mithra Pharmaceuticals Basic Information
10.15.2 Mithra Pharmaceuticals Contraceptives Product Overview
10.15.3 Mithra Pharmaceuticals Contraceptives Product Market Performance
10.15.4 Mithra Pharmaceuticals Business Overview
10.15.5 Mithra Pharmaceuticals Recent Developments
11 CONTRACEPTIVES MARKET FORECAST BY REGION
11.1 Global Contraceptives Market Size Forecast
11.2 Global Contraceptives Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Contraceptives Market Size Forecast by Country
11.2.3 Asia Pacific Contraceptives Market Size Forecast by Region
11.2.4 South America Contraceptives Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Contraceptives by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Contraceptives Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Contraceptives by Type (2026-2035)
12.1.2 Global Contraceptives Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Contraceptives by Type (2026-2035)
12.2 Global Contraceptives Market Forecast by Application (2026-2035)
12.2.1 Global Contraceptives Sales (K MT) Forecast by Application
12.2.2 Global Contraceptives Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Contraceptives
1.2 Key Market Segments
1.2.1 Contraceptives Segment by Type
1.2.2 Contraceptives Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 CONTRACEPTIVES MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Contraceptives Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Contraceptives Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 CONTRACEPTIVES MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Contraceptives Product Life Cycle
3.3 Global Contraceptives Sales by Manufacturers (2020-2025)
3.4 Global Contraceptives Revenue Market Share by Manufacturers (2020-2025)
3.5 Contraceptives Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Contraceptives Average Price by Manufacturers (2020-2025)
3.7 Manufacturers’ Manufacturing Sites, Areas Served, and Product Types
3.8 Contraceptives Market Competitive Situation and Trends
3.8.1 Contraceptives Market Concentration Rate
3.8.2 Global 5 and 10 Largest Contraceptives Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 CONTRACEPTIVES INDUSTRY CHAIN ANALYSIS
4.1 Contraceptives Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF CONTRACEPTIVES MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Contraceptives Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy – April 2025
5.6.3 Global Trade Frictions and Their Impacts to Contraceptives Market
5.7 ESG Ratings of Leading Companies
6 CONTRACEPTIVES MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Contraceptives Sales Market Share by Type (2020-2025)
6.3 Global Contraceptives Market Size by Type (2020-2025)
6.4 Global Contraceptives Price by Type (2020-2025)
7 CONTRACEPTIVES MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Contraceptives Market Sales by Application (2020-2025)
7.3 Global Contraceptives Market Size (M USD) by Application (2020-2025)
7.4 Global Contraceptives Sales Growth Rate by Application (2020-2025)
8 CONTRACEPTIVES MARKET SALES BY REGION
8.1 Global Contraceptives Sales by Region
8.1.1 Global Contraceptives Sales by Region
8.1.2 Global Contraceptives Sales Market Share by Region
8.2 Global Contraceptives Market Size by Region
8.2.1 Global Contraceptives Market Size by Region
8.2.2 Global Contraceptives Market Size by Region
8.3 North America
8.3.1 North America Contraceptives Sales by Country
8.3.2 North America Contraceptives Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Contraceptives Sales by Country
8.4.2 Europe Contraceptives Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Contraceptives Sales by Region
8.5.2 Asia Pacific Contraceptives Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Contraceptives Sales by Country
8.6.2 South America Contraceptives Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Contraceptives Sales by Region
8.7.2 Middle East and Africa Contraceptives Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 CONTRACEPTIVES MARKET PRODUCTION BY REGION
9.1 Global Production of Contraceptives by Region(2020-2025)
9.2 Global Contraceptives Revenue Market Share by Region (2020-2025)
9.3 Global Contraceptives Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Contraceptives Production
9.4.1 North America Contraceptives Production Growth Rate (2020-2025)
9.4.2 North America Contraceptives Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Contraceptives Production
9.5.1 Europe Contraceptives Production Growth Rate (2020-2025)
9.5.2 Europe Contraceptives Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Contraceptives Production (2020-2025)
9.6.1 Japan Contraceptives Production Growth Rate (2020-2025)
9.6.2 Japan Contraceptives Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Contraceptives Production (2020-2025)
9.7.1 China Contraceptives Production Growth Rate (2020-2025)
9.7.2 China Contraceptives Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Bayer
10.1.1 Bayer Basic Information
10.1.2 Bayer Contraceptives Product Overview
10.1.3 Bayer Contraceptives Product Market Performance
10.1.4 Bayer Business Overview
10.1.5 Bayer SWOT Analysis
10.1.6 Bayer Recent Developments
10.2 Pfizer
10.2.1 Pfizer Basic Information
10.2.2 Pfizer Contraceptives Product Overview
10.2.3 Pfizer Contraceptives Product Market Performance
10.2.4 Pfizer Business Overview
10.2.5 Pfizer SWOT Analysis
10.2.6 Pfizer Recent Developments
10.3 Teva
10.3.1 Teva Basic Information
10.3.2 Teva Contraceptives Product Overview
10.3.3 Teva Contraceptives Product Market Performance
10.3.4 Teva Business Overview
10.3.5 Teva SWOT Analysis
10.3.6 Teva Recent Developments
10.4 Actavis
10.4.1 Actavis Basic Information
10.4.2 Actavis Contraceptives Product Overview
10.4.3 Actavis Contraceptives Product Market Performance
10.4.4 Actavis Business Overview
10.4.5 Actavis Recent Developments
10.5 Gedeon Richter
10.5.1 Gedeon Richter Basic Information
10.5.2 Gedeon Richter Contraceptives Product Overview
10.5.3 Gedeon Richter Contraceptives Product Market Performance
10.5.4 Gedeon Richter Business Overview
10.5.5 Gedeon Richter Recent Developments
10.6 ZiZhu
10.6.1 ZiZhu Basic Information
10.6.2 ZiZhu Contraceptives Product Overview
10.6.3 ZiZhu Contraceptives Product Market Performance
10.6.4 ZiZhu Business Overview
10.6.5 ZiZhu Recent Developments
10.7 Baijingyu
10.7.1 Baijingyu Basic Information
10.7.2 Baijingyu Contraceptives Product Overview
10.7.3 Baijingyu Contraceptives Product Market Performance
10.7.4 Baijingyu Business Overview
10.7.5 Baijingyu Recent Developments
10.8 Sine
10.8.1 Sine Basic Information
10.8.2 Sine Contraceptives Product Overview
10.8.3 Sine Contraceptives Product Market Performance
10.8.4 Sine Business Overview
10.8.5 Sine Recent Developments
10.9 Reckitt
10.9.1 Reckitt Basic Information
10.9.2 Reckitt Contraceptives Product Overview
10.9.3 Reckitt Contraceptives Product Market Performance
10.9.4 Reckitt Business Overview
10.9.5 Reckitt Recent Developments
10.10 AbbVie
10.10.1 AbbVie Basic Information
10.10.2 AbbVie Contraceptives Product Overview
10.10.3 AbbVie Contraceptives Product Market Performance
10.10.4 AbbVie Business Overview
10.10.5 AbbVie Recent Developments
10.11 Church and Dwight
10.11.1 Church and Dwight Basic Information
10.11.2 Church and Dwight Contraceptives Product Overview
10.11.3 Church and Dwight Contraceptives Product Market Performance
10.11.4 Church and Dwight Business Overview
10.11.5 Church and Dwight Recent Developments
10.12 Cooper Companies
10.12.1 Cooper Companies Basic Information
10.12.2 Cooper Companies Contraceptives Product Overview
10.12.3 Cooper Companies Contraceptives Product Market Performance
10.12.4 Cooper Companies Business Overview
10.12.5 Cooper Companies Recent Developments
10.13 TherapeuticsMD
10.13.1 TherapeuticsMD Basic Information
10.13.2 TherapeuticsMD Contraceptives Product Overview
10.13.3 TherapeuticsMD Contraceptives Product Market Performance
10.13.4 TherapeuticsMD Business Overview
10.13.5 TherapeuticsMD Recent Developments
10.14 Afaxys
10.14.1 Afaxys Basic Information
10.14.2 Afaxys Contraceptives Product Overview
10.14.3 Afaxys Contraceptives Product Market Performance
10.14.4 Afaxys Business Overview
10.14.5 Afaxys Recent Developments
10.15 Mithra Pharmaceuticals
10.15.1 Mithra Pharmaceuticals Basic Information
10.15.2 Mithra Pharmaceuticals Contraceptives Product Overview
10.15.3 Mithra Pharmaceuticals Contraceptives Product Market Performance
10.15.4 Mithra Pharmaceuticals Business Overview
10.15.5 Mithra Pharmaceuticals Recent Developments
11 CONTRACEPTIVES MARKET FORECAST BY REGION
11.1 Global Contraceptives Market Size Forecast
11.2 Global Contraceptives Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Contraceptives Market Size Forecast by Country
11.2.3 Asia Pacific Contraceptives Market Size Forecast by Region
11.2.4 South America Contraceptives Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Contraceptives by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Contraceptives Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Contraceptives by Type (2026-2035)
12.1.2 Global Contraceptives Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Contraceptives by Type (2026-2035)
12.2 Global Contraceptives Market Forecast by Application (2026-2035)
12.2.1 Global Contraceptives Sales (K MT) Forecast by Application
12.2.2 Global Contraceptives Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Contraceptives Market Size by Type (M USD)
Table 4. Global Contraceptives Market Size by Application
Table 5. Contraceptives Market Size Comparison by Region (M USD)
Table 6. Global Contraceptives Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Contraceptives Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Contraceptives Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Contraceptives Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Contraceptives as of 2025)
Table 11. Global Market Contraceptives Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers’ Manufacturing Sites, Areas Served
Table 13. Manufacturers’ Product Type
Table 14. Global Contraceptives Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Contraceptives Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Contraceptives Sales by Type (K MT)
Table 27. Global Contraceptives Market Size by Type (M USD)
Table 28. Global Contraceptives Sales (K MT) by Type (2020-2025)
Table 29. Global Contraceptives Sales Market Share by Type (2020-2025)
Table 30. Global Contraceptives Market Size (M USD) by Type (2020-2025)
Table 31. Global Contraceptives Market Share by Type (2020-2025)
Table 32. Global Contraceptives Price (USD/KG) by Type (2020-2025)
Table 33. Global Contraceptives Sales (K MT) by Application
Table 34. Global Contraceptives Market Size by Application
Table 35. Global Contraceptives Sales by Application (2020-2025) & (K MT)
Table 36. Global Contraceptives Sales Market Share by Application (2020-2025)
Table 37. Global Contraceptives Market Size by Application (2020-2025) & (M USD)
Table 38. Global Contraceptives Market Share by Application (2020-2025)
Table 39. Global Contraceptives Sales Growth Rate by Application (2020-2025)
Table 40. Global Contraceptives Sales by Region (2020-2025) & (K MT)
Table 41. Global Contraceptives Sales Market Share by Region (2020-2025)
Table 42. Global Contraceptives Market Size by Region (2020-2025) & (M USD)
Table 43. Global Contraceptives Market Size by Region (2020-2025)
Table 44. North America Contraceptives Sales by Country (2020-2025) & (K MT)
Table 45. North America Contraceptives Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Contraceptives Sales by Country (2020-2025) & (K MT)
Table 47. Europe Contraceptives Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Contraceptives Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Contraceptives Market Size by Region (2020-2025) & (M USD)
Table 50. South America Contraceptives Sales by Country (2020-2025) & (K MT)
Table 51. South America Contraceptives Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Contraceptives Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Contraceptives Market Size by Region (2020-2025) & (M USD)
Table 54. Global Contraceptives Production (K MT) by Region(2020-2025)
Table 55. Global Contraceptives Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Contraceptives Revenue Market Share by Region (2020-2025)
Table 57. Global Contraceptives Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Contraceptives Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Contraceptives Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Contraceptives Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Contraceptives Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Bayer Basic Information
Table 63. Bayer Contraceptives Product Overview
Table 64. Bayer Contraceptives Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Bayer Business Overview
Table 66. Bayer SWOT Analysis
Table 67. Bayer Recent Developments
Table 68. Pfizer Basic Information
Table 69. Pfizer Contraceptives Product Overview
Table 70. Pfizer Contraceptives Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Pfizer Business Overview
Table 72. Pfizer SWOT Analysis
Table 73. Pfizer Recent Developments
Table 74. Teva Basic Information
Table 75. Teva Contraceptives Product Overview
Table 76. Teva Contraceptives Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Teva Business Overview
Table 78. Teva SWOT Analysis
Table 79. Teva Recent Developments
Table 80. Actavis Basic Information
Table 81. Actavis Contraceptives Product Overview
Table 82. Actavis Contraceptives Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Actavis Business Overview
Table 84. Actavis Recent Developments
Table 85. Gedeon Richter Basic Information
Table 86. Gedeon Richter Contraceptives Product Overview
Table 87. Gedeon Richter Contraceptives Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Gedeon Richter Business Overview
Table 89. Gedeon Richter Recent Developments
Table 90. ZiZhu Basic Information
Table 91. ZiZhu Contraceptives Product Overview
Table 92. ZiZhu Contraceptives Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. ZiZhu Business Overview
Table 94. ZiZhu Recent Developments
Table 95. Baijingyu Basic Information
Table 96. Baijingyu Contraceptives Product Overview
Table 97. Baijingyu Contraceptives Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Baijingyu Business Overview
Table 99. Baijingyu Recent Developments
Table 100. Sine Basic Information
Table 101. Sine Contraceptives Product Overview
Table 102. Sine Contraceptives Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Sine Business Overview
Table 104. Sine Recent Developments
Table 105. Reckitt Basic Information
Table 106. Reckitt Contraceptives Product Overview
Table 107. Reckitt Contraceptives Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. Reckitt Business Overview
Table 109. Reckitt Recent Developments
Table 110. AbbVie Basic Information
Table 111. AbbVie Contraceptives Product Overview
Table 112. AbbVie Contraceptives Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. AbbVie Business Overview
Table 114. AbbVie Recent Developments
Table 115. Church and Dwight Basic Information
Table 116. Church and Dwight Contraceptives Product Overview
Table 117. Church and Dwight Contraceptives Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 118. Church and Dwight Business Overview
Table 119. Church and Dwight Recent Developments
Table 120. Cooper Companies Basic Information
Table 121. Cooper Companies Contraceptives Product Overview
Table 122. Cooper Companies Contraceptives Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 123. Cooper Companies Business Overview
Table 124. Cooper Companies Recent Developments
Table 125. TherapeuticsMD Basic Information
Table 126. TherapeuticsMD Contraceptives Product Overview
Table 127. TherapeuticsMD Contraceptives Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 128. TherapeuticsMD Business Overview
Table 129. TherapeuticsMD Recent Developments
Table 130. Afaxys Basic Information
Table 131. Afaxys Contraceptives Product Overview
Table 132. Afaxys Contraceptives Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 133. Afaxys Business Overview
Table 134. Afaxys Recent Developments
Table 135. Mithra Pharmaceuticals Basic Information
Table 136. Mithra Pharmaceuticals Contraceptives Product Overview
Table 137. Mithra Pharmaceuticals Contraceptives Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 138. Mithra Pharmaceuticals Business Overview
Table 139. Mithra Pharmaceuticals Recent Developments
Table 140. Global Contraceptives Sales Forecast by Region (2026-2035) & (K MT)
Table 141. Global Contraceptives Market Size Forecast by Region (2026-2035) & (M USD)
Table 142. North America Contraceptives Sales Forecast by Country (2026-2035) & (K MT)
Table 143. North America Contraceptives Market Size Forecast by Country (2026-2035) & (M USD)
Table 144. Europe Contraceptives Sales Forecast by Country (2026-2035) & (K MT)
Table 145. Europe Contraceptives Market Size Forecast by Country (2026-2035) & (M USD)
Table 146. Asia Pacific Contraceptives Sales Forecast by Region (2026-2035) & (K MT)
Table 147. Asia Pacific Contraceptives Market Size Forecast by Region (2026-2035) & (M USD)
Table 148. South America Contraceptives Sales Forecast by Country (2026-2035) & (K MT)
Table 149. South America Contraceptives Market Size Forecast by Country (2026-2035) & (M USD)
Table 150. Middle East and Africa Contraceptives Sales Forecast by Country (2026-2035) & (Units)
Table 151. Middle East and Africa Contraceptives Market Size Forecast by Country (2026-2035) & (M USD)
Table 152. Global Contraceptives Sales Forecast by Type (2026-2035) & (K MT)
Table 153. Global Contraceptives Market Size Forecast by Type (2026-2035) & (M USD)
Table 154. Global Contraceptives Price Forecast by Type (2026-2035) & (USD/KG)
Table 155. Global Contraceptives Sales (K MT) Forecast by Application (2026-2035)
Table 156. Global Contraceptives Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Contraceptives Market Size by Type (M USD)
Table 4. Global Contraceptives Market Size by Application
Table 5. Contraceptives Market Size Comparison by Region (M USD)
Table 6. Global Contraceptives Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Contraceptives Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Contraceptives Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Contraceptives Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Contraceptives as of 2025)
Table 11. Global Market Contraceptives Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers’ Manufacturing Sites, Areas Served
Table 13. Manufacturers’ Product Type
Table 14. Global Contraceptives Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Contraceptives Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Contraceptives Sales by Type (K MT)
Table 27. Global Contraceptives Market Size by Type (M USD)
Table 28. Global Contraceptives Sales (K MT) by Type (2020-2025)
Table 29. Global Contraceptives Sales Market Share by Type (2020-2025)
Table 30. Global Contraceptives Market Size (M USD) by Type (2020-2025)
Table 31. Global Contraceptives Market Share by Type (2020-2025)
Table 32. Global Contraceptives Price (USD/KG) by Type (2020-2025)
Table 33. Global Contraceptives Sales (K MT) by Application
Table 34. Global Contraceptives Market Size by Application
Table 35. Global Contraceptives Sales by Application (2020-2025) & (K MT)
Table 36. Global Contraceptives Sales Market Share by Application (2020-2025)
Table 37. Global Contraceptives Market Size by Application (2020-2025) & (M USD)
Table 38. Global Contraceptives Market Share by Application (2020-2025)
Table 39. Global Contraceptives Sales Growth Rate by Application (2020-2025)
Table 40. Global Contraceptives Sales by Region (2020-2025) & (K MT)
Table 41. Global Contraceptives Sales Market Share by Region (2020-2025)
Table 42. Global Contraceptives Market Size by Region (2020-2025) & (M USD)
Table 43. Global Contraceptives Market Size by Region (2020-2025)
Table 44. North America Contraceptives Sales by Country (2020-2025) & (K MT)
Table 45. North America Contraceptives Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Contraceptives Sales by Country (2020-2025) & (K MT)
Table 47. Europe Contraceptives Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Contraceptives Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Contraceptives Market Size by Region (2020-2025) & (M USD)
Table 50. South America Contraceptives Sales by Country (2020-2025) & (K MT)
Table 51. South America Contraceptives Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Contraceptives Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Contraceptives Market Size by Region (2020-2025) & (M USD)
Table 54. Global Contraceptives Production (K MT) by Region(2020-2025)
Table 55. Global Contraceptives Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Contraceptives Revenue Market Share by Region (2020-2025)
Table 57. Global Contraceptives Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Contraceptives Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Contraceptives Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Contraceptives Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Contraceptives Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Bayer Basic Information
Table 63. Bayer Contraceptives Product Overview
Table 64. Bayer Contraceptives Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Bayer Business Overview
Table 66. Bayer SWOT Analysis
Table 67. Bayer Recent Developments
Table 68. Pfizer Basic Information
Table 69. Pfizer Contraceptives Product Overview
Table 70. Pfizer Contraceptives Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Pfizer Business Overview
Table 72. Pfizer SWOT Analysis
Table 73. Pfizer Recent Developments
Table 74. Teva Basic Information
Table 75. Teva Contraceptives Product Overview
Table 76. Teva Contraceptives Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Teva Business Overview
Table 78. Teva SWOT Analysis
Table 79. Teva Recent Developments
Table 80. Actavis Basic Information
Table 81. Actavis Contraceptives Product Overview
Table 82. Actavis Contraceptives Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Actavis Business Overview
Table 84. Actavis Recent Developments
Table 85. Gedeon Richter Basic Information
Table 86. Gedeon Richter Contraceptives Product Overview
Table 87. Gedeon Richter Contraceptives Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Gedeon Richter Business Overview
Table 89. Gedeon Richter Recent Developments
Table 90. ZiZhu Basic Information
Table 91. ZiZhu Contraceptives Product Overview
Table 92. ZiZhu Contraceptives Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. ZiZhu Business Overview
Table 94. ZiZhu Recent Developments
Table 95. Baijingyu Basic Information
Table 96. Baijingyu Contraceptives Product Overview
Table 97. Baijingyu Contraceptives Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Baijingyu Business Overview
Table 99. Baijingyu Recent Developments
Table 100. Sine Basic Information
Table 101. Sine Contraceptives Product Overview
Table 102. Sine Contraceptives Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Sine Business Overview
Table 104. Sine Recent Developments
Table 105. Reckitt Basic Information
Table 106. Reckitt Contraceptives Product Overview
Table 107. Reckitt Contraceptives Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. Reckitt Business Overview
Table 109. Reckitt Recent Developments
Table 110. AbbVie Basic Information
Table 111. AbbVie Contraceptives Product Overview
Table 112. AbbVie Contraceptives Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. AbbVie Business Overview
Table 114. AbbVie Recent Developments
Table 115. Church and Dwight Basic Information
Table 116. Church and Dwight Contraceptives Product Overview
Table 117. Church and Dwight Contraceptives Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 118. Church and Dwight Business Overview
Table 119. Church and Dwight Recent Developments
Table 120. Cooper Companies Basic Information
Table 121. Cooper Companies Contraceptives Product Overview
Table 122. Cooper Companies Contraceptives Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 123. Cooper Companies Business Overview
Table 124. Cooper Companies Recent Developments
Table 125. TherapeuticsMD Basic Information
Table 126. TherapeuticsMD Contraceptives Product Overview
Table 127. TherapeuticsMD Contraceptives Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 128. TherapeuticsMD Business Overview
Table 129. TherapeuticsMD Recent Developments
Table 130. Afaxys Basic Information
Table 131. Afaxys Contraceptives Product Overview
Table 132. Afaxys Contraceptives Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 133. Afaxys Business Overview
Table 134. Afaxys Recent Developments
Table 135. Mithra Pharmaceuticals Basic Information
Table 136. Mithra Pharmaceuticals Contraceptives Product Overview
Table 137. Mithra Pharmaceuticals Contraceptives Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 138. Mithra Pharmaceuticals Business Overview
Table 139. Mithra Pharmaceuticals Recent Developments
Table 140. Global Contraceptives Sales Forecast by Region (2026-2035) & (K MT)
Table 141. Global Contraceptives Market Size Forecast by Region (2026-2035) & (M USD)
Table 142. North America Contraceptives Sales Forecast by Country (2026-2035) & (K MT)
Table 143. North America Contraceptives Market Size Forecast by Country (2026-2035) & (M USD)
Table 144. Europe Contraceptives Sales Forecast by Country (2026-2035) & (K MT)
Table 145. Europe Contraceptives Market Size Forecast by Country (2026-2035) & (M USD)
Table 146. Asia Pacific Contraceptives Sales Forecast by Region (2026-2035) & (K MT)
Table 147. Asia Pacific Contraceptives Market Size Forecast by Region (2026-2035) & (M USD)
Table 148. South America Contraceptives Sales Forecast by Country (2026-2035) & (K MT)
Table 149. South America Contraceptives Market Size Forecast by Country (2026-2035) & (M USD)
Table 150. Middle East and Africa Contraceptives Sales Forecast by Country (2026-2035) & (Units)
Table 151. Middle East and Africa Contraceptives Market Size Forecast by Country (2026-2035) & (M USD)
Table 152. Global Contraceptives Sales Forecast by Type (2026-2035) & (K MT)
Table 153. Global Contraceptives Market Size Forecast by Type (2026-2035) & (M USD)
Table 154. Global Contraceptives Price Forecast by Type (2026-2035) & (USD/KG)
Table 155. Global Contraceptives Sales (K MT) Forecast by Application (2026-2035)
Table 156. Global Contraceptives Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Contraceptives
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Contraceptives Market Size (M USD), 2025-2035
Figure 5. Global Contraceptives Market Size (M USD) (2020-2035)
Figure 6. Global Contraceptives Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Contraceptives Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Contraceptives Product Life Cycle
Figure 13. Contraceptives Sales Share by Manufacturers in 2025
Figure 14. Global Contraceptives Revenue Share by Manufacturers in 2025
Figure 15. Contraceptives Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Contraceptives Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Contraceptives Revenue in 2025
Figure 18. Industry Chain Map of Contraceptives
Figure 19. Global Contraceptives Market PEST Analysis
Figure 20. Global Contraceptives Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Contraceptives Market Share by Type
Figure 27. Sales Market Share of Contraceptives by Type (2020-2025)
Figure 28. Sales Market Share of Contraceptives by Type in 2025
Figure 29. Market Share of Contraceptives by Type (2020-2025)
Figure 30. Market Share of Contraceptives by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Contraceptives Market Share by Application
Figure 33. Global Contraceptives Sales Market Share by Application (2020-2025)
Figure 34. Global Contraceptives Sales Market Share by Application in 2025
Figure 35. Global Contraceptives Market Share by Application (2020-2025)
Figure 36. Global Contraceptives Market Share by Application in 2025
Figure 37. Global Contraceptives Sales Growth Rate by Application (2020-2025)
Figure 38. Global Contraceptives Sales Market Share by Region (2020-2025)
Figure 39. Global Contraceptives Market Size by Region (2020-2025)
Figure 40. North America Contraceptives Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Contraceptives Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Contraceptives Sales Market Share by Country in 2024
Figure 43. North America Contraceptives Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Contraceptives Market Size by Country in 2024
Figure 45. U.S. Contraceptives Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Contraceptives Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Contraceptives Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Contraceptives Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Contraceptives Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Contraceptives Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Contraceptives Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Contraceptives Sales Market Share by Country in 2024
Figure 53. Europe Contraceptives Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Contraceptives Market Size by Country in 2024
Figure 55. Germany Contraceptives Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Contraceptives Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Contraceptives Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Contraceptives Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Contraceptives Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Contraceptives Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Contraceptives Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Contraceptives Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Contraceptives Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Contraceptives Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Contraceptives Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Contraceptives Sales Market Share by Region in 2024
Figure 67. Asia Pacific Contraceptives Market Size by Region in 2024
Figure 68. China Contraceptives Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Contraceptives Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Contraceptives Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Contraceptives Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Contraceptives Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Contraceptives Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Contraceptives Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Contraceptives Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Contraceptives Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Contraceptives Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Contraceptives Sales and Growth Rate (K MT)
Figure 79. South America Contraceptives Sales Market Share by Country in 2024
Figure 80. South America Contraceptives Market Size and Growth Rate (M USD)
Figure 81. South America Contraceptives Market Size by Country in 2024
Figure 82. Brazil Contraceptives Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Contraceptives Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Contraceptives Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Contraceptives Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Contraceptives Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Contraceptives Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Contraceptives Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Contraceptives Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Contraceptives Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Contraceptives Market Size by Region in 2024
Figure 92. Saudi Arabia Contraceptives Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Contraceptives Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Contraceptives Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Contraceptives Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Contraceptives Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Contraceptives Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Contraceptives Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Contraceptives Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Contraceptives Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Contraceptives Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Contraceptives Production Market Share by Region (2020-2025)
Figure 103. North America Contraceptives Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Contraceptives Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Contraceptives Production (K MT) Growth Rate (2020-2025)
Figure 106. China Contraceptives Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Contraceptives Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Contraceptives Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Contraceptives Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Contraceptives Market Share Forecast by Type (2026-2035)
Figure 111. Global Contraceptives Sales Forecast by Application (2026-2035)
Figure 112. Global Contraceptives Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of Contraceptives
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Contraceptives Market Size (M USD), 2025-2035
Figure 5. Global Contraceptives Market Size (M USD) (2020-2035)
Figure 6. Global Contraceptives Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Contraceptives Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Contraceptives Product Life Cycle
Figure 13. Contraceptives Sales Share by Manufacturers in 2025
Figure 14. Global Contraceptives Revenue Share by Manufacturers in 2025
Figure 15. Contraceptives Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Contraceptives Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Contraceptives Revenue in 2025
Figure 18. Industry Chain Map of Contraceptives
Figure 19. Global Contraceptives Market PEST Analysis
Figure 20. Global Contraceptives Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Contraceptives Market Share by Type
Figure 27. Sales Market Share of Contraceptives by Type (2020-2025)
Figure 28. Sales Market Share of Contraceptives by Type in 2025
Figure 29. Market Share of Contraceptives by Type (2020-2025)
Figure 30. Market Share of Contraceptives by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Contraceptives Market Share by Application
Figure 33. Global Contraceptives Sales Market Share by Application (2020-2025)
Figure 34. Global Contraceptives Sales Market Share by Application in 2025
Figure 35. Global Contraceptives Market Share by Application (2020-2025)
Figure 36. Global Contraceptives Market Share by Application in 2025
Figure 37. Global Contraceptives Sales Growth Rate by Application (2020-2025)
Figure 38. Global Contraceptives Sales Market Share by Region (2020-2025)
Figure 39. Global Contraceptives Market Size by Region (2020-2025)
Figure 40. North America Contraceptives Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Contraceptives Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Contraceptives Sales Market Share by Country in 2024
Figure 43. North America Contraceptives Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Contraceptives Market Size by Country in 2024
Figure 45. U.S. Contraceptives Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Contraceptives Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Contraceptives Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Contraceptives Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Contraceptives Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Contraceptives Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Contraceptives Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Contraceptives Sales Market Share by Country in 2024
Figure 53. Europe Contraceptives Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Contraceptives Market Size by Country in 2024
Figure 55. Germany Contraceptives Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Contraceptives Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Contraceptives Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Contraceptives Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Contraceptives Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Contraceptives Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Contraceptives Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Contraceptives Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Contraceptives Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Contraceptives Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Contraceptives Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Contraceptives Sales Market Share by Region in 2024
Figure 67. Asia Pacific Contraceptives Market Size by Region in 2024
Figure 68. China Contraceptives Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Contraceptives Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Contraceptives Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Contraceptives Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Contraceptives Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Contraceptives Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Contraceptives Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Contraceptives Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Contraceptives Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Contraceptives Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Contraceptives Sales and Growth Rate (K MT)
Figure 79. South America Contraceptives Sales Market Share by Country in 2024
Figure 80. South America Contraceptives Market Size and Growth Rate (M USD)
Figure 81. South America Contraceptives Market Size by Country in 2024
Figure 82. Brazil Contraceptives Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Contraceptives Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Contraceptives Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Contraceptives Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Contraceptives Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Contraceptives Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Contraceptives Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Contraceptives Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Contraceptives Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Contraceptives Market Size by Region in 2024
Figure 92. Saudi Arabia Contraceptives Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Contraceptives Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Contraceptives Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Contraceptives Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Contraceptives Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Contraceptives Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Contraceptives Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Contraceptives Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Contraceptives Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Contraceptives Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Contraceptives Production Market Share by Region (2020-2025)
Figure 103. North America Contraceptives Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Contraceptives Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Contraceptives Production (K MT) Growth Rate (2020-2025)
Figure 106. China Contraceptives Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Contraceptives Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Contraceptives Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Contraceptives Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Contraceptives Market Share Forecast by Type (2026-2035)
Figure 111. Global Contraceptives Sales Forecast by Application (2026-2035)
Figure 112. Global Contraceptives Market Share Forecast by Application (2026-2035)
More Publications
Global Soft Gelatin Capsules Market Research Report 2026(Status and Outlook)
US$ 2,980.00
February 2026
170 pages
Global Insulin API Market Research Report 2026(Status and Outlook)
US$ 2,980.00
February 2026
139 pages
Global Sleep Aid Device Market Research Report 2025(Status and Outlook)
US$ 3,200.00
July 2025
146 pages
Global POC Blood Gas and Electrolyte Market Research Report 2026(Status and Outlook)
US$ 2,980.00
February 2026
153 pages
Global At Home Health Testing Platform Market Research Report 2025(Status and Outlook)
US$ 3,200.00
July 2025
146 pages
